Deutsch English Français Italiano |
<vi2k5c$2vb53$1@dont-email.me> View for Bookmarking (what is this?) Look up another Usenet article |
Path: ...!eternal-september.org!feeder2.eternal-september.org!news.eternal-september.org!.POSTED!not-for-mail From: Olivier @ <mon.arobase@free.fr> Newsgroups: fr.bio.medecine Subject: Re: =?ISO-8859-15?Q?Cancers_:_une_=E9volution_pr=E9occupante_pour?= =?ISO-8859-15?Q?_le_poumon_et_le_pancr=E9as_chez_les_femmes?= Date: Mon, 25 Nov 2024 20:45:46 +0100 Organization: A noiseless patient Spider Lines: 10 Message-ID: <vi2k5c$2vb53$1@dont-email.me> References: <oPuSO.1422532$jVLc.1339836@fx15.ams4> <MPG.4184e05af9bbff7298a5e6@news.individual.net> <vfkjla$3ck4$1@solani.org> <MPG.4188eff15642ca8998a5ee@news.individual.net> <vg0906$1lq3m$1@solani.org> <YiZUO.3246420$grz1.195845@fx03.ams4> <vg9v8q$5a2q$1@solani.org> <MPG.4193789716cde23c98a5f2@news.individual.net> <vge0fj$h9d1$1@solani.org> <MPG.4194c4e8fd48e55598a5f4@news.individual.net> <vgf2p5$hspm$1@solani.org> <vgf80e$21eq8$1@dont-email.me> <vgfgv4$86qp$1@solani.org> <vghtdd$2j0eg$1@dont-email.me> <vh73is$740c$1@solani.org> <vh77jo$3c605$1@dont-email.me> <vh7g22$7avh$1@solani.org> <vhf1id$166to$1@dont-email.me> <xaI_O.36080$9Qsf.26172@fx07.ams4> <vhfpt0$1av8p$1@dont-email.me> <Mrf%O.88807$7Lh8.14231@fx11.ams4> <vhl7pg$73qi$1@dont-email.me> <N5K%O.93606$8co7.77948@fx06.ams4> <vho5u5$pu0s$1@dont-email.me> <WsW0P.145487$Tr7c.67293@fx04.ams4> <vi2fm4$2u1g6$1@dont-email.me> <Zr41P.141958$7Lh8.58210@fx11.ams4> MIME-Version: 1.0 Content-Type: text/plain; charset="iso-8859-15"; format=flowed Content-Transfer-Encoding: 8bit Injection-Date: Mon, 25 Nov 2024 20:45:48 +0100 (CET) Injection-Info: dont-email.me; posting-host="d2f8bcdddc2b59502bcc2d696523ace1"; logging-data="3124387"; mail-complaints-to="abuse@eternal-september.org"; posting-account="U2FsdGVkX1//HjDVOSJO2dcpS+9Fb3Er" Cancel-Lock: sha1:LHjRzD/PyAM1tGaDpX2n7GEuki0= X-Newsreader: MesNews/1.08.06.00 Bytes: 2246 Paul Aubrin a exprim� avec pr�cision : > Le 25/11/2024 � 19:29, Olivier@ a �crit�: >>> En sciences, on ne discute pas des personnes, mais de la validit� des >>> hypoth�ses. >> >> Merci d'avoir enfonc� une nouvelle porte ouverte ! > > Vous aimez tant l'argument d'autorit�, mais en sciences, il ne vaut rien. Une autre ! Une autre ! Une autre !